Early experience with intravitreal bevacizumab combined with laser treatment for retinopathy of prematurity

Middle East African Journal of Ophthalmology

Volumn 18, Issue 2, 2011, Pages 196-197

  Raizada, Seemant ^a   Al Kandari, Jamal ^a   Al Foudari, Ahmad ^a  

^a IBN SINA HOSPITAL   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

ANTIANGIOGENIC ACTIVITY; CILIARY DISK; EYE DEVELOPMENT; GENERAL ANESTHESIA; HIGH RISK PATIENT; HUMAN; LASER SURGERY; LETTER; OFF LABEL DRUG USE; PRIORITY JOURNAL; RETINA DETACHMENT; RETROLENTAL FIBROPLASIA; TRACTIONAL RETINA DETACHMENT; VISUAL IMPAIRMENT;

EID: 79956285939     PISSN: 09749233     EISSN: 09751599     Source Type: Journal    
DOI: 10.4103/0974-9233.80716     Document Type: Letter

References (5)

1. Ahmed AE, Channa R, Durrani J, Ali A, Ahmad K. Early experience with intravitreal bevacizumab combined with laser treatment for retinopathy of prematurity. Middle East Afr J Ophthalmol 2010;17:264-7.
2. Wani VB, Kumar N, Sabti K, Raizada S, Rashwan N, Shukkur MM, et al. Results of screening for retinopathy of prematurity in a large nursery in Kuwait: Incidence and risk factors. Indian J Ophthalmol 2010;58:204-8.
3. Nicholson BP, Schachat AP. A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2010;248:915-30.
4. Kusaka S, Shima C, Wada K, Arahori H, Shimojyo H, Sato T, et al. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: A pilot study. Br J Ophthalmol 2008;92:1450-5.
5. Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: Results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003;121:1684-94.